Simon Geale

19 February 2021
Topics in this article
  • Cost Optimization
  • Value Chain

When the UK approved the Pfizer/BioNTech Covid-19 vaccine in December, it became the first country in the world to do so. Now dozens of nations are grappling with unprecedented challenges to get the vaccine from the manufacturers, into the arms of millions of people, and fast.

Over the last month, I have been speaking to international broadcast media about the challenges that vaccine distribution has brought to supply chains, highlighting the triumphs of global collaboration and the lessons we’ve learned so far.

Building efficient supply chains is important for ensuring all moving parts, from manufacturing and financial agreements, to shipping and distribution, work together in perfect harmony. When building these supply chains, primary goals might be to minimize cost or balance risk. Some countries chose speed as their goal, and with this comes an acceptance of higher cost and risk built into their calculations.

The world has never faced a situation quite like this, so it’s important that the key players laying down the tracks share their learnings as early as possible. This brings with it risks and arising problems that governments will need to overcome and adapt to, but the data is most important. Through global collaboration, we can ensure efficiency across global vaccine rollouts.

Watch my full interview with Euronews below to learn more.

Let’s talk.

If you are looking to drive purposeful and profitable change, get in touch.

Contact us